- 著者
- Makoto Yamakawa Keiichi Nakahara Toshihito Nakanishi Toshiya Nomura Mitsuharu Ueda
- 出版者
- The Japanese Society of Internal Medicine
- 雑誌
- Internal Medicine (ISSN:09182918)
- 巻号頁・発行日
- vol.61, no.7, pp.1067-1069, 2022-04-01 (Released:2022-04-01)
- 参考文献数
- 14
- 被引用文献数
- 13
After BNT162b2 messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccination, a 30-year-old man developed bilateral lateral gaze palsy, diplopia, absent tendon reflexes, and ataxic gait. Serum anti-GQ1b and anti-GT1a immunoglobulin G (IgG) antibodies were strongly positive. Based on those findings, he was diagnosed with Miller Fisher syndrome (MFS). Intravenous immunoglobulin therapy was administered, and his symptoms fully recovered within approximately 3 months. To the best of our knowledge, this is the first report to describe the development of MFS after COVID-19 mRNA vaccination.
言及状況
外部データベース (DOI)
Twitter (29 users, 29 posts, 35 favorites)
#GBS #diplopia https://t.co/0ypYNfFjCz
Dangerous diseases cause by @pfizer vaccine:
"After BNT162b2 messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccination, a 30-year-old man developed bilateral lateral gaze palsy, diplopia, absent tendon reflexes, and ataxic gait."
https://t.co/4DzVUANgfD
Miller Fisher Syndrome Following Vaccination
30-year-old man developed bilateral lateral gaze palsy, diplopia, absent tendon reflexes, and ataxic gait after the #Pfizer shot,he was diagnosed with Miller Fisher syndrome
https://t.co/3mFV7ahnNH
Pour infos : un syndrome de Fisher Miller après vax Pfizer, homme 30 ans : Ce syndrome est caractérisé par une triade clinique à début brusque, avec ataxie à la marche, aréflexie, et ophtalmoplégie. Peut avoir paralysie faciale https://t.co/Qa2tn1Pok3